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Primary small intestinal liposarcomas originating in the small bowel are uncommon with a generally poor prognosis due to the
advanced stage at the time of diagnosis. We describe a case of primary small bowel dediﬀerentiated liposarcoma presenting as a
solid mass in the right iliac fossa. The current case is unusual as the tumour seemingly originated from the bowel and the well-
diﬀerentiated component was seen extensively inﬁltrating the bowel wall including the small bowel submucosa.
1.Introduction
Primary small intestinal malignant mesenchymal tumours
are uncommon, and liposarcomas originating in the small
bowel are extraordinarily rare [1]. The early clinical symp-
toms of these malignancies are nonspeciﬁc and for this
reason the disease is often diagnosed at an advanced stage.
The prognosis of these lesions is generally poor owing
to the diﬀusion of the disease at the time of diagnosis.
Usually small bowel neoplasms are preoperatively identiﬁed
only in 27–72% of cases and the percentage of surgical
removal is from 65–80% in clinical literature [2]. We
report the clinical, radiological, and pathologic ﬁndings of a
primary small bowel dediﬀerentiated-type liposarcoma with
divergent myogenic diﬀerentiation.
2.CaseReport
A 59-year-old gentleman presented with a history of right
iliac fossa mass. The CT scan showed a solid mass not
obviously attached to the small or large bowel and had
a possible fatty component at the edge (Figure 1(a)). The
biopsy was reported as a malignant pleomorphic spindle
cell lesion, which demonstrated strong positivity for SMA
and desmin, whilst S100 and c-kit were negative. There
was one mitosis per 10hpf and no necrosis. Taking the
radiological information into account, diﬀerential diagnosis
of dediﬀerentiated liposarcoma with myogenic diﬀerenti-
ation or a primary retroperitoneal leiomyosarcoma were
suggested. Resection specimen received later comprised of a
small bowel, the midpart of which was markedly distended
by a pale mass measuring 14 × 11.5cm. The nodular mass
hadaﬁrm-creamyellowcutsurfaceandapproximately60%–
65% appeared to originate from the bowel wall. Several
satellite lesions with similar macroscopic appearances were
noted away from the main lesion.
Histology showed the lesion to be composed of well-
diﬀerentiated liposarcoma (atypical lipomatous tumour)
with abrupt transition to areas with an extensive dedif-
ferentiated component. The well-diﬀerentiated areas were
represented by adipose tissue in which atypical adipocytes
andlipoblastswereeasilyidentiﬁable(Figures1(b)and1(c)).
The dediﬀerentiated areas were represented by high-grade
pleomorphic and spindle cell sarcoma that expressed diﬀuse
strong SMA and desmin positivity indicating divergent
myogenic diﬀerentiation (Figures 1(d), 1(e),a n d1(f)). H-
caldesmon was negative in the dediﬀerentiated areas. A
diagnosis of dediﬀerentiated liposarcoma with myogenic
divergent diﬀerentiation was therefore made.
The tumour appeared to originate from the bowel
and the well-diﬀerentiated component was seen extensively2 Sarcoma
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Figure 1: (a) A solid mass in the right iliac fossa not attached to the bowel wall, (b), (c) well-diﬀerentiated liposarcoma inﬁltrating the
submucosa, (d), (e), and (f) dediﬀerentiated component inﬁltrating the small bowel, and (g), (h) well-diﬀerentiated liposarcoma at the
small bowel resection margins.
inﬁltrating the bowel wall including the small bowel sub-
mucosa. Critical examination of sections taken from the
bowelwallwellawayfrommacroscopictumourshowedwell-
diﬀerentiated liposarcoma inﬁltrating along the submucosa.
Furthermore well-diﬀerentiated liposarcoma was present at
the resection margins (Figures 1(g) and 1(h)) despite these
being at least 9cms away from the macroscopic tumour.
3. Discussion
Dediﬀerentiated liposarcoma (DDLPS) is a term ﬁrst intro-
duced by Evans in 1979 [3] to describe liposarcomas
containing a mixture of atypical lipoma/well-diﬀerentiated
liposarcoma and a high-grade nonlipogenic sarcomatous
component, the latter arising either within the same primarySarcoma 3
tumour (around 90% of cases) or in a recurrence (around
10% of cases).
The nomenclature of the low-grade component of these
tumours has been the subject of much confusion in the
literature: the original terms “atypical lipoma” and “well
diﬀerentiated liposarcoma” (WDLPS) pertain to homol-
ogous tumours arising in either the superﬁcial or deep
tissues, respectively. It was subsequently recognised that
atypical lipomas and WDLPS have no metastatic potential
withoutdediﬀerentiationandthusthenomenclatureofthese
tumours was standardised in the WHO 2002 classiﬁcation of
soft tissue tumours. Currently all these lesions are termed
atypical lipomatous tumours (ALTs) except when arising
within the retroperitoneum or mediastinum. The term
WDLPS was retained in these latter cases to emphasize that
lesions at these particular sites are very diﬃcult to eradicate,
have a high rate of dediﬀerentiation, and often prove fatal.
The risk of dediﬀerentiation occurring in ALT/WDLPS is
higher in deep-seated tumours, particularly in the retroperi-
toneum (2/3 cases), and is probably a time-dependent
phenomenon[4].DediﬀerentiationinALTdeepseatedinthe
extremities is uncommon and in subcutaneous tissue is rare.
Histologically, dediﬀerentiated liposarcoma is deﬁned
by the association of atypical lipomatous tumour/well-
diﬀerentiated liposarcoma areas and a non-lipogenic high
gradesarcoma,usuallywithanabrupttransitionbetweenthe
two components. Dediﬀerentiated areas exhibit a wide mor-
phological spectrum. Most cases show areas of high-grade
sarcoma resembling pleomorphic undiﬀerentiated sarcoma
or myxoﬁbrosarcoma. In about ﬁve to 10% of cases, the
dediﬀerentiated component shows divergent diﬀerentiation
with a myogenic or osteochondrosarcomatous element. The
genomic proﬁle of DDLPS mirrors those of ALT and
WDLPS, all of which show, on cytogenetic analysis, ring
and giant chromosomes composed of ampliﬁed sequences of
the 12q13-14 chromosome region. This amplicon is mainly
composed of the MDM2 and CDK4 genes [5]. Ampliﬁcation
of MDM2 and CDK4 may therefore be responsible for
the malignant tumour process. Dediﬀerentiated liposarcoma
shows additional complex karyotypic abnormalities.
The most important prognostic factor in DDLPS is
location with poor prognosis for retroperitoneal tumours,
largely related to diﬃculty in achieving complete clearance
of the tumour. Histological grade is not of prognostic value
[6, 7]. The clinical course of dediﬀerentiated liposarcoma
is mainly dominated by local recurrences (40%–60%).
Metastatic potential is low (15%–20%) [3, 4] despite the
tumour being a morphologically high-grade lesion. This is
presumably a reﬂection of diﬀerent molecular mechanisms
of tumour development in these lesions as opposed to other
high-grade sarcomas [5]. Indeed the rate of p53 mutation is
lower than those of other high-grade sarcomas [8]. Inter-
estingly, DDLPSs with myogenic divergent diﬀerentiation
retain the low metastatic potential of conventional DDLPSs,
signiﬁcantly lower than that of comparable leiomyosarcomas
[7]. Although WDLPSs/DDLPSs are the most common
soft tissue sarcomas in the retroperitoneum [6], and while
secondary involvement of the gastrointestinal tract can occur
in cases of retroperitoneal sarcomas, liposarcomas primarily
involvingthegastrointestinaltractareextremelyuncommon.
Occurrence of these tumours in the small intestine [6]
often presents a submucosal polyp or even intussusceptions.
The current case is highly unusual in that it originated
from, or extensively involved, the bowel wall including the
submucosa, the latter primarily as the (presumably original)
WDLPS component. Both ALT and WDLPS can recur at
some distance from the original tumour (personal experi-
e n c eT M )a n do n eo fu s(T M )h a s ,o ns e v e r a lo c c a s i o n s ,s e e n
two apparently unrelated fatty tumours prove to be a single
ALT with synchronous presentation at some distance apart
[6]. This phenomenon is good evidence that these tumours
can be more extensive than clinically, radiologically, or even
microscopically apparent because of the very close similarity
of ALT and WDLPS, in areas, to normal adipose tissue. The
currentcasedemonstratesthisphenomenonparticularlywell
with the WDLPS component seen inﬁltrating extensively
along the submucosa of the bowel wall. In the current case
the risk of recurrence will not only be the around the surgical
radial clearance margins but also at the bowel anastomosis
site and further along the bowel itself.
4. Conclusion
In summary we have presented a very unusual case of ded-
iﬀerentiated liposarcoma of the small bowel with myogenic
divergent diﬀerentiation and extensive involvement of the
small bowel submucosa. The case illustrates the particular
point that this form of tumour may be much more highly
inﬁltrative and extensive than apparent clinically and radi-
ologically. This may go some way to explain the extremely
high recurrence rates of these tumours, particularly in the
abdominal cavity.
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